title: EGFR exon 19 deletion mutations and systemic/central nervous system miliary metastasis: clinical correlations and response to therapy.
authors.affiliation: School of Medicine, University of Colorado School of Medicine, Aurora, CO.
authors.forename: Seerat
authors.initials: S
authors.lastname: Poonia
authors.affiliation: Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
authors.forename: Eamon M
authors.initials: EM
authors.lastname: Berge
authors.affiliation: Department of Pathology, University of Colorado School of Medicine, Aurora, CO.
authors.forename: Dara L
authors.initials: DL
authors.lastname: Aisner
authors.affiliation: Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
authors.forename: Denise
authors.initials: D
authors.lastname: Damek
authors.affiliation: Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO. Electronic address: robert.doebele@ucdenver.edu.
authors.forename: Robert C
authors.initials: RC
authors.lastname: Doebele
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D003072:Cognition Disorders / Q000188:drug therapy / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D066246:ErbB Receptors / Q000235:genetics*; D000069347:Erlotinib Hydrochloride; D005091:Exons; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D055756:Meningeal Carcinomatosis / Q000235:genetics / Q000473:pathology / Q000556:secondary*; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011799:Quinazolines / Q000008:administration & dosage / Q000627:therapeutic use; D017384:Sequence Deletion; D016896:Treatment Outcome
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors
keywords: EGFR; Erlotinib; Leptomeningeal; Miliary nodules; Non–small-cell lung cancer